News & Publications
Lenders request conversion of over €0.5mn in Mezzanine capital (convertible loans) into equity; resolution passed by the Board of Directors to facilitate conversion by means of approved capital increase
AgroScience Capital AG's shareholders approve all proposals of the Board of Directors at the 2024 Annual General Meeting (AGM)
Update on "plant protection" IPR portfolio: ≈ 30 international patents granted (incl. China, India, Brazil, US, Canada, Japan, all major agricultural markets in Europe, Australia etc.) on our new active ingredient (from the alkylene guanidine group) with unique CAS number for fungicidal applications and proven broad diseases control spectrum of commercially relevant phytopathogens affecting major crops
AgroScience Capital AG secures over €0.5mn in Mezzanine capital (convertible loans)
Scientific evidence as to broad diseases control spectrum of AgroScience Capital AG's proprietary active substance covering: (1) Venturia inaequalis (VENTIN), (2) Alternaria alternata (ALTEAL), (3) Neofabraea vagabunda (PEZIAL), (4) Sphaerotheca fuliginea (SPHRFU), (5) Zymoseptoria tritici (SEPTTR), (6) Botrytis cinerea (BOTRCI), (7) Fusarium avenaceum (GIBBAV), (8) Fusarium culmorum (FUSACU), (9) Fusarium graminearum (GIBBZE), (10) Phakopsora pachyrhizi (PHAKPA) and (11) Alternaria solani (ALTESOL).
AgroScience Capital AG launches broad based in-vitro and in-vivo (GH) efficacy programme with its improved "t.k." design